IMMZ.D
type: CodeSystem
node role: treeRoot
id:
  v: IMMZ.D
text:
  status:
    v: generated
  div: Generated Narrative: CodeSystem IMMZ.D This case-insensitive code system http://smart.who.int/immunizations/CodeSystem/IMMZ.D defines the following codes: Code Display Definition DE19 Vaccine type Vaccine type/category that was administered or was to be administered. Any vaccine code available in the IMMZ.Z Vaccine library list of codes applies in this data element DE20 Date and time of vaccination Represents the visit/encounter date, which is the date and time when each vaccine was administered to the client DE201 Contact date The date and time of the client's contact DE202 ANC contact number The antenatal care (ANC) contact or visit number DE124 Dose number Vaccine dose number including dose number within series DE156 Immunization recommendation status The current status or recommendation for a specific immunization for an client DE157 Not due The client is not currently eligible or scheduled for the specified immunization DE158 Due The client is currently eligible and should receive the specified immunization based on the recommended schedule DE189 Complete The client has received the specified immunization(s) based on the recommended schedule DE159 Contraindicated The specified immunization is not recommended for the client due to contraindications DE160 Further evaluation needed Additional assessment is necessary before making a recommendation regarding the specified immunization DE161 Potential contraindications Specific situations or medical conditions for which it is advised or recommended to avoid or delay administering a particular vaccine DE162 Currently pregnant The client is currently pregnant DE163 Immunocompromised The client is known to be immunocompromised DE200 Severely immunocompromised The client is known to be severely immunocompromised DE164 Exposed to immunosuppressive treatment The client is undergoing immunosuppressive treatment or was exposed to immunosuppressive treatment in utero or via breastfeeding. DE165 Severely immunosuppressed The c…
url:
  v: http://smart.who.int/immunizations/CodeSystem/IMMZ.D
version:
  v: 0.2.0
name:
  v: IMMZ_D
title:
  v: IMMZ.D CodeSystem for Data Elements
status:
  v: active
experimental:
  v: false
date:
  v: 2025-06-25T20:08:00+00:00
publisher:
  v: WHO
contact:
  name:
    v: WHO
  telecom:
    system:
      v: url
    value:
      v: http://who.int
description:
  v: CodeSystem for IMMZ.D Data Elements
case sensitive:
  v: false
content:
  v: complete
count:
  v: 194
concept:
  code:
    v: DE19
  display:
    v: Vaccine type
  definition:
    v: Vaccine type/category that was administered or was to be administered. Any vaccine code available in the IMMZ.Z Vaccine library list of codes applies in this data element
concept:
  code:
    v: DE20
  display:
    v: Date and time of vaccination
  definition:
    v: Represents the visit/encounter date, which is the date and time when each vaccine was administered to the client
concept:
  code:
    v: DE201
  display:
    v: Contact date
  definition:
    v: The date and time of the client's contact
concept:
  code:
    v: DE202
  display:
    v: ANC contact number
  definition:
    v: The antenatal care (ANC) contact or visit number
concept:
  code:
    v: DE124
  display:
    v: Dose number
  definition:
    v: Vaccine dose number including dose number within series
concept:
  code:
    v: DE156
  display:
    v: Immunization recommendation status
  definition:
    v: The current status or recommendation for a specific immunization for an client
concept:
  code:
    v: DE157
  display:
    v: Not due
  definition:
    v: The client is not currently eligible or scheduled for the specified immunization
concept:
  code:
    v: DE158
  display:
    v: Due
  definition:
    v: The client is currently eligible and should receive the specified immunization based on the recommended schedule
concept:
  code:
    v: DE189
  display:
    v: Complete
  definition:
    v: The client has received the specified immunization(s) based on the recommended schedule
concept:
  code:
    v: DE159
  display:
    v: Contraindicated
  definition:
    v: The specified immunization is not recommended for the client due to contraindications
concept:
  code:
    v: DE160
  display:
    v: Further evaluation needed
  definition:
    v: Additional assessment is necessary before making a recommendation regarding the specified immunization
concept:
  code:
    v: DE161
  display:
    v: Potential contraindications
  definition:
    v: Specific situations or medical conditions for which it is advised or recommended to avoid or delay administering a particular vaccine
concept:
  code:
    v: DE162
  display:
    v: Currently pregnant
  definition:
    v: The client is currently pregnant
concept:
  code:
    v: DE163
  display:
    v: Immunocompromised
  definition:
    v: The client is known to be immunocompromised
concept:
  code:
    v: DE200
  display:
    v: Severely immunocompromised
  definition:
    v: The client is known to be severely immunocompromised
concept:
  code:
    v: DE164
  display:
    v: Exposed to immunosuppressive treatment
  definition:
    v: The client is undergoing immunosuppressive treatment or was exposed to immunosuppressive treatment in utero or via breastfeeding.
concept:
  code:
    v: DE165
  display:
    v: Severely immunosuppressed
  definition:
    v: The client is known to be severely immunosuppressed
concept:
  code:
    v: DE187
  display:
    v: Immunodeficiency syndromes
  definition:
    v: The client has immunodeficiency syndromes (e.g. HIV/AIDS, known or suspected congenital immunodeficiency, leukaemia, lymphoma or other malignant disease)
concept:
  code:
    v: DE166
  display:
    v: History of anaphylactic reactions
  definition:
    v: The client is known to have history of anaphylaxis in the past
concept:
  code:
    v: DE167
  display:
    v: Severe allergic reactions
  definition:
    v: The client is known to have severe allergic reaction
concept:
  code:
    v: DE168
  display:
    v: Symptomatic HIV infection
  definition:
    v: The client is experiencing HIV-related symptoms
concept:
  code:
    v: DE169
  display:
    v: Planning to get pregnant in the next month
  definition:
    v: The client's intention or desire is to become pregnant in the next month
concept:
  code:
    v: DE170
  display:
    v: Receiving blood products
  definition:
    v: The client is receiving blood or blood-related products as part of a medical treatment.

code:
  v: DE188
display:
  v: Severe acute illness
definition:
  v: The client has a severe acute illness

code:
  v: DE190
display:
  v: TB disease
definition:
  v: The client has been diagnosed with tuberculosis (TB)

code:
  v: DE191
display:
  v: Breastfeeding
definition:
  v: The client is currently breastfeeding

code:
  v: DE192
display:
  v: Spina bifida
definition:
  v: The client has spina bifida

code:
  v: DE193
display:
  v: Bladder exstrophy
definition:
  v: The client has exstrophy of urinary bladder

code:
  v: DE194
display:
  v: Acute gastroenteritis
definition:
  v: The client has acute gastroenteritis

code:
  v: DE195
display:
  v: Moderate to severe fever
definition:
  v: The client has moderate to severe fever

code:
  v: DE196
display:
  v: Prior history of intussusception
definition:
  v: The client has prior history of intussusception

code:
  v: DE197
display:
  v: Altered immunocompetence
definition:
  v: The client's immune system is not functioning at its typical capacity

code:
  v: DE198
display:
  v: Hypersensitivity to vaccine components
definition:
  v: The client has heightened sensitivity or allergic reactions to specific components found in vaccines

code:
  v: DE199
display:
  v: Taking antibiotics
definition:
  v: The client is currently taking antibiotics to treat certain infections

code:
  v: DE86
display:
  v: Client education and counselling on immunization
definition:
  v: Providing information, guidance and support to client or caretakers (such as parents or legal guardians) regarding immunization practices

code:
  v: DE87
display:
  v: Counselling on functions of the immunological system
definition:
  v: Explaining to the client or caregiver how the vaccines work by triggering the body to produce an immune response

code:
  v: DE88
display:
  v: Advising about functions of the immunological system
definition:
  v: Explaining to the client or caregiver how the vaccines work by triggering the body to produce an immune response

code:
  v: DE89
display:
  v: Education to influence immunization behaviours
definition:
  v: Public health interventions to improve general and accurate understanding and impacts of vaccines, and their role in preventing various diseases

code:
  v: DE90
display:
  v: Advising about immunization behaviours
definition:
  v: Public health interventions to improve general and accurate understanding and impacts of vaccines, and their role in preventing various diseases

code:
  v: DE91
display:
  v: Awareness raising to influence immunization behaviours
definition:
  v: Public health interventions to improve general and accurate understanding and impacts of vaccines, and their role in preventing various diseases

code:
  v: DE1
display:
  v: Immunization event status
definition:
  v: The current status of the individual immunization event

code:
  v: DE2
display:
  v: Completed
definition:
  v: The immunization event was successfully carried out as intended

code:
  v: DE3
display:
  v: Entered in error
definition:
  v: Immunization event record has been mistakenly created or entered into the system. Recorded information is incorrect or should not have been documented, though it is possible that real-world decisions were based on it

code:
  v: DE4
display:
  v: Not done
definition:
  v: Planned immunization event was not carried out for some reason

code:
  v: DE5
display:
  v: Reason vaccine was not administered
definition:
  v: The reason this immunization event was not performed

code:
  v: DE6
display:
  v: Immunity
definition:
  v: Testing has shown that the client already has immunity to the agent targeted by the immunization

code:
  v: DE7
display:
  v: Medical precaution
definition:
  v: The client currently has a medical condition for which the vaccine is contraindicated or for which precaution is warranted

code:
  v: DE8
display:
  v: Product out of stock
definition:
  v: There was no supply of the product on hand to perform the service

code:
  v: DE9
display:
  v: Client objection
definition:
  v: The client or their guardian objects to receiving the vaccine

code:
  v: DE10
display:
  v: Caregiver refusal
definition:
  v: The client's caregiver refused the vaccine

code:
  v: DE11
display:
  v: Unspecified reason
definition:
  v: The immunization event was not carried out for an unspecified reason

code:
  v: DE12
display:
  v: Client allergy to vaccine or component
definition:
  v: The immunization event was not carried out because of client allergy to vaccine or component

code:
  v: DE13
display:
  v: Immunocompromised
definition:
  v: The immunization event was not carried out because the client is immunocompromised

code:
  v: DE14
display:
  v: Chronic illness or condition
definition:
  v: The immunization event was not carried out due a chronic illness or condition of the client

code:
  v: DE15
display:
  v: Acute illness
definition:
  v: The immunization event was not carried out due to an acute illness present in the client

code:
  v: DE16
display:
  v: Had the disease
definition:
  v: The immunization event was not carried out due to the client having had the disease

code:
  v: DE17
display:
  v: Immunization not carried out for other reasons
definition:
  v: The immunization event was not carried out for other reasons

code:
  v: DE18
display:
  v: Vaccine brand
definition:
  v: The brand or trade name used to refer to the vaccine received

code:
  v: DE173
display:
  v: Live vaccine
definition:
  v: Uses a living but weakened version of the virus or one that is very similar

code:
  v: DE21
display:
  v: Country of vaccination
definition:
  v: The service delivery country where the vaccine administration occurred

code:
  v: DE22
display:
  v: Administrative area
definition:
  v: The service delivery location (location name, city, municipality, town or village) where the vaccine administration occurred

code:
  v: DE23
display:
  v: Vaccine manufacturer
definition:
  v: The manufacturer of the vaccine product

code:
  v: DE24
display:
  v: Vaccine batch number
definition:
  v: Batch number or lot number of vaccine

code:
  v: DE25
display:
  v: Vaccine market authorization holder
definition:
  v: Name of the market authorization holder of the vaccine received. If market authorization holder is unknown, vaccine manufacturer is REQUIRED

code:
  v: DE26
display:
  v: Expiration date
definition:
  v: The expiration date of the vaccine

code:
  v: DE34
display:
  v: Dose quantity
definition:
  v: The quantity of vaccine product that was administered

code:
  v: DE35
display:
  v: Health worker identifier
definition:
  v: The person, organization or role of the entity that performed the act of giving the vaccine to the client. The implementing system can choose to populate this field using data from a health worker registry or health-care facility registry

code:
  v: DE125
display:
  v: Total doses in series
definition:
  v: The recommended number of doses for immunity according to the national immunization schedule (which may be based on product, age, etc.)

code:
  v: DE126
display:
  v: Disease targeted
definition:
  v: Vaccine-preventable disease being targeted

code:
  v: DE127
display:
  v: Typhoid
definition:
  v: The vaccine-preventable disease being targeted is typhoid

code:
  v: DE128
display:
  v: Influenza
definition:
  v: The vaccine-preventable disease being targeted is influenza

code:
  v: DE129
display:
  v: Measles
definition:
  v: The vaccine-preventable disease being targeted is measles

code:
  v: DE133
display:
  v: Pertussis
definition:
  v: The vaccine-preventable disease being targeted is pertussis

code:
  v: DE135
display:
  v: Mumps
definition:
  v: The vaccine-preventable disease being targeted is mumps

code:
  v: DE136
display:
  v: Varicella
definition:
  v: The vaccine-preventable disease being targeted is varicella

code:
  v: DE137
display:
  v: Viral hepatitis A
definition:
  v: The vaccine-preventable disease being targeted is viral hepatitis A

code:
  v: DE139
display:
  v: Tuberculosis
definition:
  v: The vaccine-preventable disease being targeted is TB

code:
  v: DE140
display:
  v: Viral hepatitis B
definition:
  v: The vaccine-preventable disease being targeted is viral hepatitis B

code:
  v: DE141
display:
  v: Haemophilus influenzae type b
definition:
  v: The vaccine-preventable disease being targeted is Haemophilus influenzae type b (Hib)

code:
  v: DE142
display:
  v: Tetanus
definition:
  v: The vaccine-preventable disease being targeted is tetanus

code:
  v: DE143
display:
  v: Rotavirus
definition:
  v: The vaccine-preventable disease being targeted is rotavirus

code:
  v: DE144
display:
  v: Human papillomavirus
definition:
  v: The vaccine-preventable disease being targeted is human papillomavirus (HPV) infection

code:
  v: DE175
display:
  v: Japanese encephalitis
definition:
  v: The vaccine-preventable disease being targeted is Japanese encephalitis (JE)

code:
  v: DE146
display:
  v: Poliomyelitis
definition:
  v: The vaccine-preventable disease being targeted is poliomyelitis (polio)

code:
  v: DE176
display:
  v: Diphtheria
definition:
  v: The vaccine-preventable disease being targeted is diphtheria

code:
  v: DE177
display:
  v: Pneumococcal disease
definition:
  v: The vaccine-preventable disease being targeted is pneumococcal

code:
  v: DE178
display:
  v: Rubella
definition:
  v: The vaccine-preventable disease being targeted is rubella

code:
  v: DE179
display:
  v: Dengue
definition:
  v: The vaccine-preventable disease being targeted is dengue

code:
  v: DE180
display:
  v: Rabies
definition:
  v: The vaccine-preventable disease being targeted is rabies

code:
  v: DE181
display:
  v: Meningococcal
definition:
  v: The vaccine-preventable disease being targeted is meningococcal

code:
  v: DE182
display:
  v: Cholera
definition:
  v: The vaccine-preventable disease being targeted is cholera

code:
  v: DE183
display:
  v: Tick-borne encephalitis
definition:
  v: The vaccine-preventable disease being targeted is tick-borne encephalitis (TBE)

code:
  v: DE184
display:
  v: Yellow fever
definition:
  v: The vaccine-preventable disease being targeted is yellow fever

code:
  v: DE148
display:
  v: COVID-19
definition:
  v: The vaccine-preventable disease being targeted is coronovirus disease (COVID-19)

code:
  v: DE149
display:
  v: Due date of next dose
definition:
  v: Date on which the next vaccination should be administered, if a next dose is required

code:
  v: DE92
display:
  v: Reaction reported
definition:
  v: Indicates observation of an adverse event/reaction

code:
  v: DE93
display:
  v: Reaction date
definition:
  v: When adverse event/reaction started

code:
  v: DE95
display:
  v: Reaction manifestation
definition:
  v: The manifestation of the reaction (e.g. infected abscess, swelling, rash, hives, diarrhoea, etc.) observed after administering the vaccine

code:
  v: DE96
display:
  v: Severe local reaction
definition:
  v: The client's reaction manifested in severe local reaction

code:
  v: DE98
display:
  v: Seizures
definition:
  v: The client's reaction manifested in seizures

code:
  v: DE99
display:
  v: Abscess
definition:
  v: The client's reaction manifested in an abscess

code:
  v: DE100
display:
  v: Sepsis
definition:
  v: The client's reaction manifested in sepsis

code:
  v: DE101
display:
  v: Encephalopathy
definition:
  v: The client's reaction manifested in encephalopathy

code:
  v: DE102
display:
  v: Toxic shock syndrome
definition:
  v: The client's reaction manifested in toxic shock syndrome

code:
  v: DE103
display:
  v: Anaphylaxis
definition:
  v: The client's reaction manifested in anaphylaxis

code:
  v: DE104
display:
  v: Fever
definition:
  v: The client's reaction manifested as a fever

code:
  v: DE105
display:
  v: Other
definition:
  v: The client's reaction manifested in another way

code:
  v: DE107
display:
  v: Type of reaction
definition:
  v: If the event resulted in a reaction, what is the type of reaction

code:
  v: DE174
display:
  v: Non serious
definition:
  v: The reaction resulted in a mild or minor response and did not pose a significant threat to client's health

code:
  v: DE108
display:
  v: Death
definition:
  v: The reaction resulted in the client's death

code:
  v: DE109
display:
  v: Life threatening
definition:
  v: The reaction threatened the client's life

code:
  v: DE110
display:
  v: Disability
definition:
  v: The reaction resulted in a disability

code:
  v: DE111
display:
  v: Hospitalization
definition:
  v: The reaction resulted in a hospitalization

code:
  v: DE112
display:
  v: Congenital anomaly
definition:
  v: The reaction was a congenital anomaly or birth defect

code:
  v: DE113
display:
  v: Other important medical event (specify)
definition:
  v: There was another important reaction or medical event

code:
  v: DE115
display:
  v: Reaction outcome
definition:
  v: The outcome of the reaction (e.g. death, recovered, recovering)

code:
  v: DE116
display:
  v: Died
definition:
  v: The adverse event resulted in the client's death

code:
  v: DE117
display:
  v: Recovered
definition:
  v: The client fully recovered

code:
  v: DE118
display:
  v: Recovered with sequelae
definition:
  v: The client has recovered with sequelae as a consequence of the reaction/vaccination

code:
  v: DE119
display:
  v: Recovering
definition:
  v: The client is recovering

code:
  v: DE120
display:
  v: Not recovered
definition:
  v: The client has not recovered

code:
  v: DE121
display:
  v: Unknown
definition:
  v: The client's reaction outcome is unknown

code:
  v: DE185
display:
  v: Date/time of follow-up appointment
definition:
  v: Date the client is to return for next vaccination

code:
  v: DE186
display:
  v: Recommended follow-up date
definition:
  v: Date when follow-up is recommended based on vaccination schedule

code:
  v: DE150
display:
  v: Digital certificate needed
definition:
  v: Indicates if a digital certificate is required

code:
  v: DE151
display:
  v: Certificate issuer
definition:
  v: The authority or authorized organization that issued the vaccination certificate

code:
  v: DE152
display:
  v: Health Certificate Identifier (HCID)
definition:
  v: Unique identifier used to associate the immunization event represented in a paper vaccination card to its digital representation(s)

code:
  v: DE153
display:
  v: Certificate valid from
definition:
  v: Date in which the certificate for an immunization event became valid. No health or clinical inferences should be made from this date

code:
  v: DE154
display:
  v: Certificate valid until
definition:
  v: Last date in which the certificate for an immunization event is valid. No health or clinical inferences should be made from this date

code:
  v: DE155
display:
  v: Certificate schema version
definition:
  v: Version of the core data set and HL7 Fast Health Interoperability Resources (FHIR) implementation guide that the certificate is using

code:
  v: DE263
display:
  v: Birth dose
definition:
  v: Indicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen

code:
  v: DE258
display:
  v: Type of dose
definition:
  v: The type of dose in a series that the client received

code:
  v: DE259
display:
  v: Primary series
definition:
  v: Indicates that the client received the primary vaccination series of a product/antigen. This is also applicable for antigens with one dose

code:
  v: DE260
display:
  v: Dose 0
definition:
  v: Indicates that the client received a dose of a product/ antigen that is not a part of the primary vaccination series and is administered before the primary vaccination series is provided

code:
  v: DE261
display:
  v: Supplementary dose
definition:
  v: Indicates that the client received a supplementary dose of a product/antigen

code:
  v: DE262
display:
  v: Booster dose
definition:
  v: Indicates that the client received booster dose of a product/antigen

code:
  v: DE203
display:
  v: Completed the primary vaccination series
definition:
  v: Indicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen

code:
  v: DE257
display:
  v: Completed the booster series
definition:
  v: Indicates if the client has completed the booster series of a product/antigen

code:
  v: DE242
display:
  v: Date when primary vaccination series was completed
definition:
  v: The date when the client completed the primary vaccination series (per product/antigen)

code:
  v: DE204
display:
  v: HIV status
definition:
  v: The current HIV status of the client

code:
  v: DE205
display:
  v: HIV-positive
definition:
  v: The client is known to be HIV-positive

code:
  v: DE206
display:
  v: HIV-negative
definition:
  v: The client is known to be HIV-negative

code:
  v: DE207
display:
  v: Unknown
definition:
  v: The client's HIV status is unknown

code:
  v: DE208
display:
  v: Preterm birth
definition:
  v: The infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks

code:
  v: DE209
display:
  v: Immunocompromised
definition:
  v: The client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases

code:
  v: DE210
display:
  v: Currently on ART
definition:
  v: The client is currently receiving antiretroviral therapy (ART)

code:
  v: DE243
display:
  v: Type of TB infection test performed
definition:
  v: The type of tuberculosis (TB) infection test performed

code:
  v: DE244
display:
  v: IGRA
definition:
  v: Interferon-gamma release assay (IGRA)

code:
  v: DE245
display:
  v: TST
definition:
  v: Tuberculin skin test (TST)

code:
  v: DE246
display:
  v: TB infection test result
definition:
  v: Records the result of the TB infection test

code:
  v: DE247
display:
  v: Positive
definition:
  v: Test result was positive

code:
  v: DE248
display:
  v: Negative
definition:
  v: Test result was negative

code:
  v: DE249
display:
  v: Immunologically stable
definition:
  v: The client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines

code:
  v: DE250
display:
  v: Clinically well
definition:
  v: The client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging

code:
  v: DE211
display:
  v: Birth weight in grams
definition:
  v: Represents the client's birth weight value measures in grams

code:
  v: DE212
display:
  v: Type of poliovirus dose
definition:
  v: The type of the poliovirus vaccine dose administered to the client

code:
  v: DE213
display:
  v: IPV
definition:
  v: Inactivated polio vaccine (IPV)

code:
  v: DE214
display:
  v: bOPV
definition:
  v: Bivalent oral polio vaccine (bOPV)

code:
  v: DE215
display:
  v: ART start date
definition:
  v: The date on which the client started or restarted ART

code:
  v: DE251
display:
  v: High risk of pneumococcal infection
definition:
  v: The client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease)

code:
  v: DE216
display:
  v: Type of JE dose
definition:
  v: The type of Japanese encephalitis (JE) vaccine dose administered to the client

code:
  v: DE217
display:
  v: Inactivated Vero cell-derived vaccine
definition:
  v: Inactivated Vero cell-derived JE vaccine type

code:
  v: DE218
display:
  v: Live attenuated vaccine
definition:
  v: Live attenuated JE vaccine type

code:
  v: DE219
display:
  v: Live recombinant vaccine
definition:
  v: Live recombinant JE vaccine type

code:
  v: DE220
display:
  v: Type of TBE dose
definition:
  v: The type of tick-borne encephalitis (TBE) vaccine dose administered

code:
  v: DE221
display:
  v: FSME-Immun
definition:
  v: FSME-Immun vaccine product, which is an inactivated whole-virus vaccine for TBE

code:
  v: DE222
display:
  v: Encepur
definition:
  v: Encepur vaccine product, which is an inactivated viral vaccine for TBE

code:
  v: DE223
display:
  v: TBE-Moscow
definition:
  v: TBE-Moscow vaccine product, which is a vaccine for TBE

code:
  v: DE224
display:
  v: EnceVir
definition:
  v: EnceVir vaccine product, which is a vaccine for TBE

code:
  v: DE225
display:
  v: Type of typhoid dose
definition:
  v: The type of typhoid vaccine dose administered to the client

code:
  v: DE226
display:
  v: Typbar-TCV
definition:
  v: Typbar typhoid conjugate vaccine (Typbar-TCV)

code:
  v: DE227
display:
  v: ViPS
definition:
  v: Vi polysaccharide (ViPS) vaccine

code:
  v: DE228
display:
  v: Ty21a
definition:
  v: Ty21a vaccine

code:
  v: DE229
display:
  v: Type of cholera dose
definition:
  v: The type of cholera vaccine dose administered to the client

code:
  v: DE230
display:
  v: WC vaccine
definition:
  v: Killed whole-cell (WC) only cholera vaccine

code:
  v: DE231
display:
  v: WC-rBS vaccine
definition:
  v: Vaccine contains a mixture of the recombinant B subunit (rBS) of cholera toxin plus killed WC

code:
  v: DE232
display:
  v: Type of meningococcal dose
definition:
  v: The type of meningococcal vaccine dose administered to the client

code:
  v: DE233
display:
  v: MenA conjugate vaccine (5µg)
definition:
  v: Monovalent serogroup A (MenA) conjugate vaccine (5µg)

code:
  v: DE234
display:
  v: Monovalent MenC conjugate
definition:
  v: Monovalent MenC conjugate vaccine

code:
  v: DE235
display:
  v: Quadrivalent conjugate
definition:
  v: Quadrivalent conjugate (A,C,W135,Y-D and A,C,W135,Y-CRM) vaccines

code:
  v: DE252
display:
  v: Polysaccharide vaccine
definition:
  v: Polysaccharide vaccines not including polysaccharide-protein conjugate vaccines

code:
  v: DE236
display:
  v: Age in months when client received first meningococcal dose
definition:
  v: The age in months when client received their first meningococcal dose

code:
  v: DE237
display:
  v: Type of hepatitis A dose
definition:
  v: The type of hepatitis A-containing vaccine dose administered to the client

code:
  v: DE238
display:
  v: Live attenuated hepatitis A vaccine
definition:
  v: Live attenuated hepatitis A vaccine

code:
  v: DE239
display:
  v: Inactivated hepatitis A vaccine
definition:
  v: Inactivated hepatitis A vaccine

code:
  v: DE254
display:
  v: Type of hepatitis B dose
definition:
  v: The type of hepatitis B-containing vaccine dose administered to the client

code:
  v: DE255
display:
  v: Hepatitis B monovalent vaccine
definition:
  v: Hepatitis B monovalent vaccine

code:
  v: DE256
display:
  v: Hepatitis B combination vaccine
definition:
  v: Hepatitis B combination vaccine

code:
  v: DE240
display:
  v: VNA level
definition:
  v: Vaccine-induced neutralizing antibody (VNA) level, measured as a serum antibody concentration from the result of the concentrated, purified cell culture-derived and embryonated egg-based rabies vaccines (CCEEV)

code:
  v: DE253
display:
  v: Risk of occupational exposure to rabies virus
definition:
  v: Professional at risk of occupational exposure to rabies virus, particularly animal health workers. Also considered for medical professionals who regularly provide care to persons with rabies

code:
  v: DE241
display:
  v: Dengue serostatus
definition:
  v: Indicates the result of a serological test determining whether the client has antibodies against the dengue virus

code:
  v: DE264
display:
  v: Positive
definition:
  v: The client has detectable antibodies against the dengue virus, suggesting past exposure or vaccination

code:
  v: DE265
display:
  v: Negative
definition:
  v: The client does not have detectable antibodies, indicating no previous exposure or vaccination against the dengue virus

code:
  v: DE266
display:
  v: Unknown
definition:
  v: The client's dengue serostatus is unknown